This is the authors' abstract. We don't add key points for this paper.
Acquired amegakaryocytic thrombocytopenia (AATP) is a thrombocytopenic disorder characterized by a decrease in megakaryocytes in the bone marrow. AATP is effectively treated with immunosuppressive therapy. We report a case of a 68-years-old male referred to us due to purpuric lesions on the extremities and was noted to be thrombocytopenic. Bone marrow biopsy showed AATP with autoimmune hemolytic anemia (AIHA). Only two cases of AATP associated with AIHA have been reported. AATP should be differentiated carefully from other causes of peripheral destruction of platelets, such as immune thrombocytopenia (ITP).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: